Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Biosite Charts. Click Here for more Biosite Charts.](/p.php?pid=staticchart&s=N%5EBSTE&p=8&t=15)
Reminder - Biosite(R) Incorporated to Conduct 1st Quarter Results
Conference Call
SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE) announces the following Webcast:
Biosite Incorporated will announce 2005 first quarter results on Thursday,
April 21, 2005 following the close of the market. The Company will webcast a
conference call on the same day (April 21) at 1:30 p.m. PDT.
What: Biosite Announces 1st Quarter Results Conference Call
When: Thursday, April 21, 2005 at 1:30 p.m. PDT
Where: phx.corporate-ir.net/playerlink.zhtml?c=69046&s=wm&e=1049605
OR http://www.biosite.com/
How: Live over the Internet -- Simply log onto the web at the
address above.
Telephonic: US/Canada/Int'l Dial #: 706-634-7088
Conference ID# 5418856
You may dial *0 at any time for Operator assistance
Contact: Simona Dixon
Corporate and Investor Relations
Biosite Incorporated
858.455.4808 ext. 3221
email:
If you are unable to participate during the live webcast, the call will be
archived on the Biosite web site http://www.biosite.com/ until May 12th, 2005
at 2:30 p.m. PDT. The telephone replay number for U.S. callers is
800-642-1687. International callers can dial 706-645-9291- Conference ID#
5418856. The telephone replay will be available until May 12, 2005.
Company press releases may be found at http://www.biosite.com/
About Biosite: A leader in the drive to advance diagnosis, Biosite Incorporated
is a research-based company dedicated to the discovery and development of novel
protein-based diagnostic tests that improve a physician's ability to diagnose
debilitating and life-threatening diseases. The Company combines integrated
discovery and diagnostics businesses to access proteomics research, identify
proteins with high diagnostic utility, develop and commercialize products and
educate the medical community on new diagnostic approaches that improve health
care outcomes. Biosite's Triage(R) brand rapid diagnostic tests are used in
approximately 50 percent of U.S. hospitals and in more than 50 international
markets. Biosite's commercialized products include the Triage BNP Test to aid
in the diagnosis and severity assessment of heart failure, the Triage Cardiac
Panel to aid in the diagnosis of heart attacks and the Triage Drugs of Abuse
Products for the diagnosis of drug overdose. These tests can deliver critical
diagnostic information to physicians within 10 to 20 minutes. Information
about Biosite can be found at http://www.biosite.com/.
(Minimum Requirements to listen to broadcast: The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp and at least a
28.8Kbps connection to the Internet.)
DATASOURCE: Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate & Investor Relations
of Biosite Incorporated, +1-858-455-4808, ext. 3187
Web site: http://www.biosite.com/
Company News On-Call: http://www.prnewswire.com/comp/116737.html